No price history available.

Not enough data to calculate KvantraRank

Based on consensus from external analysts. Not Kvantra's opinion.

Vilin Bio Med Ltd. is a domestic pharmaceutical company primarily engaged in the manufacturing and trading of pharmaceutical products, with a focus on generic formulations across various therapeutic segments. The company produces pharmaceutical formulations such as oral liquids, dry syrups, sachets, external preparations, beta and non-beta lactam tablets and capsules, and nutritional food supplements. These products address therapeutic areas including anti-infectives, analgesics, cardiovascular, musculoskeletal, antibiotic, central nervous system, alimentary system, genito-urinary tract, respiratory system, anti-allergic, and anti-diabetic conditions. Vilin Bio Med also engages in contract manufacturing and the distribution of its own branded generics, supplying products in bulk to pharmaceutical manufacturers, marketers, and traders. Beyond pharmaceuticals, the company offers a range of cosmetics, including products for baby care, skin care, oral care, and hair care, such as serums, oils, lotions, creams, cleansers, moisturizers, and masks. The primary target market for Vilin Bio Med is the domestic Indian market, which generates over 90% of its revenue, though it also has international operations and a U.S. subsidiary for marketing and distribution in the United States, alongside a presence in GCC, Africa, EU, and Asia.

• Vasundhara Rasayans Limited
• Phaarmasia Limited
• Eastgate Biotech Corp.
• Paranovus Entertainment Technology Ltd.
• POMDOCTOR Ltd
• HealthWarehouse.com, Inc.
• Stenocare A/S
• Integrated BioPharma, Inc.